AzTrials
AzTrials

Post Intensive Care SyndromeFICUFNCT05984069

Impact of Frailty and ICU-AW on Post-ICU Fatigue Self-reported

An observational study of Post Intensive Care Syndrome, run by Centre Hospitalier Universitaire de Saint Etienne at 2 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

After a prolonged stay in Intensive Care Unit (ICU), fatigue is the most common symptom reported by patients in the Post Intensive Care Syndrome (PICS). Other complications have been described, including ICU-acquired weakness, leading to increased morbidity and mortality after discharge. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post Intensive Care Syndrome
What is being tested?
observational prospective data collection
How many people
150 participants
Where
2 sitesFrance
Study dates
1 Jul 2022to Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients admitted to intensive care, all etiologies combined, excluding immediate post-operative scheduled surgery, with mechanical ventilation for more than 5 days or length of stay in ICU over 10 days.

Who may be able to join

  • Patients with a length of stay in intensive care > or equal to 7 days, or mechanical ventilation > or equal to 5 days

Who cannot join

  • Scheduled surgery with admission in ICU
  • Pregnancy
  • Guardianship

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France2 sites, 2 recruiting
  • Chu Saint-Etienne

    Saint-Etienne, 42000

    Jérôme MOREL, MD PhD, (0)4 77 82 85 53 ext. +33, jerome.morel@chu-st-etienne.fr

    Jérôme MOREL, MD PhD

    Recruiting
  • Hôpital Privé de la Loire

    Saint-Etienne

    Laurent GERGELE, MD

    Benoît CREMILLIEUX, MD

    Recruiting

Other trials in France

About this study

After a prolonged stay in Intensive Care Unit (ICU), fatigue is the most common symptom reported by patients in the Post Intensive Care Syndrome (PICS). Other complications have been described, including ICU-acquired weakness, leading to increased morbidity and mortality after discharge. Actually, risk factors associated with post-ICU fatigue self-reported are not really known.

Read the detailed description

Frailty, defined as a decrease in physiological reserves leading to an alteration in the mechanisms of adaptation to stress, increases the incidence of PICS and could therefore be a cause of post-ICU fatigue self-reported.

The aim of this study is to identify a relationship between markers of frailty, ICU-AW, ICU story and the post-ICU fatigue self-reported 6 months discharge in patients with prolonged ICU stays.

Being tested
observational prospective data collection
Keywords
Intensive Care Unit, frailty, fatigue, ICU acquired-weakness, FACIT-F, physical activity
Medical subject headings
postintensive care syndrome, Frailty, Fatigue, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • observational prospective data collectionOther

    Collection of data from medical records.

Study groups in NCT05984069
Study groupRoleWhat they receive
Patients on etiologiesPatients over 18 admitted in ICU for all etiologies with mechanical ventilation over 5 days or length of stay in ICU over 10 days will be included
Receives: Other: observational prospective data collection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frailty

    Relationship between frailty markers (CFS, IADL, sarcopenia and myosteatosis), ICU-AW, ICU story and post-ICU fatigue self-reported

    Measured: 1 year

Secondary outcomes (4)
  1. Fatigue

    Prevalence of post-ICU fatigue self-reported 6 months discharge in prospective cohort

    Measured: 1 year

  2. ICU-acquired weakness and fatigue

    Correlation between post-ICU fatigue self-reported and muscular strength assessed by handgrip test

    Measured: 1 year

  3. Fatigue, quality of life, anxiety and depressive disorder

    Correlation between fatigue, quality of life, anxiety and depressive disorder

    Measured: 1 year

  4. Kinetic of muscle mass loss and post-ICU fatigue self-reported

    Correlation between the kinetic of muscle mass loss and post-ICU fatigue self-reported

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2023
  2. Study start1 Jul 2022
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05984069
Sponsor's protocol ID
IRBN962022/CHUSTE
Acronym
FICUF
Status last verified
Mar 2025
First submitted
2 Aug 2023
Last updated
18 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Post Intensive Care Syndrome, run by Centre Hospitalier Universitaire de Saint Etienne at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jérôme MOREL, MD PhD ((0)477828553 ext. +33, jerome.morel@chu-st-etienne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frailty (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in